Aurinia Pharmaceuticals Inc (AUPH)

Operating Income Growth

130.75%

Quarterly · Period ending:

AUPH logo

AUPH Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported130.75%
AUPH Quarterly Operating Income YoY % (-315.83% → 130.75%)
High-resolution chart · PNG

AUPH operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc Operating Income Growth — Quarterly
Period endingOperating Income Growth
130.7474%
89.6004%
2,091.5518%
153.192%
1,427.3629%
304.273%
94.3755%
172.2376%
90.6432%
63.8487%
-5.6014%
-71.2075%
55.0696%
21.9049%
14.0804%
81.1352%
23.6454%
25.05%
-306.1724%
-18.9956%
-75.4607%
-86.7812%
61.4737%
-76.2317%
-63.2612%
-81.7938%
-42.5356%
-70.1942%
-14.742%
-14.0875%
-20.7925%
-2.306%
-42.7008%
-17.6996%
-51.2648%
-155.8442%
-120.7601%
-128.6982%
-45.2752%
16.1481%
24.7852%
13.0739%
-14.1087%
-52.6841%
-32.4869%
-49.7717%
-258.9425%
-313.6145%
-405.9228%
-355.8323%
76.1043%
39.7942%
52.7358%
-121.5576%
-201.3499%
-52.5534%
-0.2273%
311.2594%
10.5608%
21.2492%
-211.0086%
-92.8447%
-22.4482%
19.518%
73.5901%
64.0899%
21.9524%
53.5627%
58.3454%
50.0643%
75.989%
53.8432%
42.9463%
26.7015%
-49.2252%
-22.2347%
-57.6707%
-44.809%
36.0076%
-17.744%
11.062%
33.2751%
-9.7131%
15.1006%
-74.4567%
-114.844%
-63.9607%
-61.29%
-325.984%
-5.3401%
-71.7625%
-338.7944%
-22.9237%
-36.9869%
180.8854%
170.4492%
-3.7812%
-32.9568%
-87.4459%
-175.1994%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.